Elsevier

Pharmacological Research

Volume 128, February 2018, Pages 338-344
Pharmacological Research

Review
Effect of resveratrol on cognitive and memory performance and mood: A meta-analysis of 225 patients

https://doi.org/10.1016/j.phrs.2017.08.009Get rights and content

Abstract

Resveratrol is a natural dietary phenolic compound which is extensively present in many edible fruits, including grape, berries, pomegranates, and peanuts. Reseveratrol has a broad spectrum of biological activities including anti-aging, chemopreventive, anti-carcinogenic, anti-inflammatory and antioxidant effects and thus it is effective in related diseases. Particularly, the positive effects of resveratrol in neuropsychological diseases have been proven in in-vitro and in-vivo studies. Some clinical trials have reported that resveratrol possesses preventive and therapeutic effects in cognitive disorders. Therefore, the current systematic review and meta-analysis aimed to assess the effects of resveratrol on cognition and memory performance as well as mood state. Electronic databases including Scopus, PubMed, Science Direct, and Cochrane library were searched with the keywords “Memory”, “Cognitive”, “Cognition” or “Mood” with “Resveratrol” until June 2017. Only clinical studies were included in this review. We have provided the most reliable evidence to date counting results obtained from 226 individuals from four randomized clinical trials evaluating the mentioned specific effects of resveratrol. The results of this meta-analysis showed that resveratrol has no significant effect on memory and cognitive performance assessed by auditory verbal learning tests. Two parameters of Profile of Mood States (POMS) including vigor and fatigue, decreased significantly by resveratrol. However, decrease in other parameters of POMS including tense/anxiety, depression, anger, and confusion by resveratrol was not significant.

The key findings from this meta-analysis are that resveratrol has no significant impact on factors related to memory and cognitive performance, including learning ability, delayed recall, retention, and recognition with all effect sizes non-significant and effectively at zero. However, it has the potential to enhance mood. Further randomized, controlled trials are needed to achieve more conclusive results.

Introduction

Aging is a natural process that comes with several chronic diseases and disabilities. Most of existing reports address the role of mitochondria in the progression of aging and neurodegenerative illnesses. This process is mediated through production of extra reactive oxygen species that leads to oxidative stress and a progressive apoptosis and cell death [1]. Neurodegeneration is one of the early consequences of aging that reflects itself as brain dysfunctions such as dementia [2]. Despite a wide range of efforts for developing therapeutic approaches, no curative treatment for cognitive decline and dementia currently exists [1]. The increase of life expectancy over the last century is associated with an enhanced number of individuals with cognitive impairment, that results in a massive social and economic burden on healthcare systems as well as society [3]. Statistic shows that approximately 47 million people worldwide suffer from dementia and this number is predictable to become double every 20 reaching about 132 million by 2050 [4].

Phytoalexins are stress-induced metabolites that are produced in response to pathogen attacks and have a specific role in the plant defense. Resveratrol (3,5,4′-trihydroxy-trans-stilbene), is a natural phytoalexin from the stilbenes subgroup [5], [6]. Resveratrol oligomers are the largest group of oligomeric stilbenes. In terms of chemical structure, resveratrol comprises a double bond that may undergo cis or trans isomerization, with two phenolic rings positioned on each end of the double bond [5], [6], [7], [8]. Resveratrol is a natural dietary phenolic compound which is extensively present in many edible fruits, including grape skin, blueberries, cranberries, bilberries, lingonberries, partridgeberries, pomegranates, mulberries, peanuts, Polygonum cuspidatum (Sieb. & Zucc.) (family, Polygonaceae), and strawberries [5], [6], [7]. Among human dietary sources, red wine represents a remarkable amount of resveratrol. The concentration of resveratrol in red wine ranging from 0.4 to 57 μM depends on the geographic origin and its type [6], [8]. Natural phytoalexin may be helpful in the management of some age and oxidative stress related disorders [9], [10]. Generally, polyphenols such as resveratrol have limitations of kinetics if used in human like rapid metabolism and elimination, and thus scientists try to find better formulations for such products. In this regard, some studies have been conducted to improve bioavailability of resveratrol and its products [9], [11]. These investigations are commonly according to suppression of cytochrome P450 (CYPs) by means of specific inhibitors, encapsulations, and structure modifications [11], [12]. This natural dietary supplement possesses the ability to cross the blood-brain barrier indicating the potential to perform the therapeutic effect on brain tissue [13]. Like other phenolic compounds, resveratrol is frequently recognized for its antioxidant function, and it has been found to alleviate human oxidative damage associated disorders as well as degenerative diseases [13], [14], [15]. In an animal study, chronic injections of trans-resveratrol showed a significant improvement of spatial memory in the Morris water maze test, particularly in animals with streptozotocin (STZ)-induced cognitive impairment. This natural phytoalexin is also able to prevent the pathological condition result in hippocampal neurodegeneration and cognitive impairment in rodent model of neurodegeneration [15], [16]. In a primate study, 18 months intake of resveratrol as dietary supplementation could significantly increase cognition and memory performance [17]. Current studies suggest that resveratrol is one of the most promising molecules for treatment of cognitive diseases. In this regard, various neuropharmacological studies revealed several intracellular targets for resveratrol in related diseases [5], [13], [15], [17]. Likewise, some clinical trials have investigated the efficacy of resveratrol in the enhancement of cognitive and memory performance and concluded that resveratrol preparations were effective [18], [19]. Contrarily, some investigations reported no efficacy of resveratrol in the improvement of cognition and memory [20], [21]. Thus, present review and meta-analysis was conducted to determine the efficacy of resveratrol in cognitive and memory performance as well as mood using data from available clinical trials.

Section snippets

Data sources and searches

A literature search was conducted on the electronic databases of Scopus, Pubmed, Science Direct, and Cochrane Central Register of Controlled Trials. The search was carried out without time restriction from 1966 to June 2017 using following search strings in the title/abstract/keywords: “Memory AND Resveratrol, Cognitive AND Resveratrol, Cognition AND Resveratrol, Mood AND Resveratrol”. All the relevant papers were included, irrespective of when and where they were conducted and whether they are

Results

The electronic searches yielded 852 items; 46 from PubMed, 655 from Scopus, 100 from Science Direct, and 51 from the Cochrane Library. Of these, 8 trials were scrutinized in full text. Four reports were considered ineligible: one had Investigating the effects of resveratrol in patients with schizophrenia [23], one exclusively focused on study design without any results [24], and 2 had investigated single dose-acute administration of resveratrol [20], [21]. Thus, 4 trials were included in the

Discussion

This systematic review and meta-analysis aimed to determine the effects of resveratrol on cognitive and memory performance as well as mood state in healthy participants and subjects with mild cognitive impairment. Neuropharmacological studies based on cellular and animal models showed that resveratrol has a marked effect on cognitive and memory function [5], [13], [15], [16], [17]. Enhanced production of brain-derived neurotrophic factor (BDNF) with specific role on cognitive loss improvement

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Acknowledgments

Authors wish to thank INSF and TUMS.

References (31)

  • M.J. Prince

    World Alzheimer Report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends

    Alzheimers Dis. Int.

    (2015)
  • T. Ahmed et al.

    Resveratrol and Alzheimer's disease: mechanistic insights

    Mol. Neurobiol.

    (2017)
  • J. Tomé-Carneiro et al.

    Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

    Cur. Pharm. Des.

    (2013)
  • S. Ehala et al.

    Characterization of phenolic profiles of Northern European berries by capillary electrophoresis and determination of their antioxidant activity

    J. Agric. Food. Chem.

    (2005)
  • J.M. Smoliga et al.

    Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?

    Molecules

    (2014)
  • Cited by (66)

    View all citing articles on Scopus
    View full text